Tag - value-driven stock selection

pharmaceutical manufacturing and investments | sheaff brock investment advisors

After the Recent Election, There’s New Reason to Love the Unloved

In certain oversold industries, it’s been a long, long stretch with stocks deprived of investors’ love and appreciation, observes Sheaff Brock Chief Investment Officer Dave Gilreath. Over-regulation and disfavor have swung the “affection pendulum” away from certain basic areas of our economy, Gilreath points out, including: pharmaceuticals industrials “traditional” energy (coal, natural gas, oil) After all, Gilreath reasons, with an aging population, the importance of pharmaceuticals and medical devices isn’t going away. Similarly, as the Energy Xchange emphasizes, “renewables have [...]